Marché mondial des dispositifs et équipements de traitement de l’infertilité – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché

Selon les Nations Unies, le taux de fécondité mondial devrait chuter à 2,4 naissances par femme d'ici 2030 et à 2,2 naissances par femme d'ici 2050. (ONU). Actuellement, 46 % de la population mondiale réside dans des pays à faible taux de fécondité. 46 % supplémentaires vivent dans des pays à fécondité intermédiaire et les 8 % restants vivent dans des pays à forte fécondité.      

Français Data Bridge Market Research analyse que le marché des appareils et équipements de traitement de l'infertilité, qui était de 1 249,80 millions USD en 2021, devrait atteindre 2 508,64 millions USD d'ici 2029 et devrait connaître un TCAC de 9,10 % au cours de la période de prévision de 2022 à 2029. Le rapport de marché élaboré par l'équipe de Data Bridge Market Research comprend une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Définition du marché

Le marché des dispositifs et équipements de traitement de l'infertilité est dominé par les dispositifs de séparation des spermatozoïdes. Dans la plupart des techniques de procréation assistée, comme la FIV et l'insémination artificielle, des dispositifs de séparation des spermatozoïdes sont utilisés. Ces instruments sont essentiels pour les techniques de procréation assistée, car ils fournissent des échantillons purs pour les opérations ultérieures.

Portée du rapport et segmentation du marché

Infertility Treatment Devices and Equipment Market Dynamics

Drivers

• Increasing Incidence of Infertility in Both Sexes

Infertility is defined by the World Health Organization as an individual's inability to achieve a healthy clinical pregnancy. Infertility can affect both men and women, however the majority of research on the problem has been conducted on women. The average number of children a woman has is referred to as her fertility rate. The global fertility rate is gradually declining due to a variety of variables, including an increase in late marriages and an increase in age-related infertility.

• Innovation and enhancement of technology

The success rate of treatments is increasing as technology improves. For example, increased demand for cryosystems and other associated devices will emerge from the development of storage equipment for temperature-sensitive sperm samples.

• Improvements in assisted reproductive treatments

Time-lapse imaging is one of the most cutting-edge infertility therapies. Time-lapse imaging can be utilised to examine the embryo development process at regular intervals without disturbing the culture. Embryos would be taken out of the incubator every day to be evaluated in earlier monitoring procedures. Embryos can continue in the incubator without disturbing their growth because to advances in technology and the usage of computers.

Opportunities

Many causes contribute to low conception rates, thus the number of people seeking infertility therapy will increase in the future years. Many companies have created novel devices and procedures for fertility treatment that are simple, effective, and cost-effective. The rising incidence of infertility in both sexes and the rising number of fertility clinics and infertility services with government assistance are key factors driving market expansion.

Restraints/Challenges

• Multiplicity and risk of preterm delivery

Several pregnancies are more likely when more than one foetus is transplanted to the mother's uterus during IVF infertility therapy, and if the babies are multiple, the risk of preterm delivery is higher. According to certain research, embryos that grow through IVF infertility treatment are born prematurely and weigh less than normal.

• Ovarian hyperstimulation syndrome

Infertile women utilise injectable fertility medicines like gonadotropins to help them ovulate during IVF infertility treatment. As a result, they develop ovarian hyperstimulation syndrome, which produces swollen and painful ovaries. Mild abdominal pain, bloating, nausea, diarrhoea, and vomiting are common symptoms of this syndrome, which subside after a week. Rapid weight gain and shortness of breath are ovarian hyperstimulation syndrome symptoms.

• Abortion

The rate of miscarriage in women who get pregnant through IVF is the same as it is in women who get pregnant naturally, although the rate of miscarriage rises with the mother's age.

This infertility treatment devices and equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infertility treatment devices and equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Infertility Treatment Devices and Equipment Market

COVID-19 sickness began to spread over the world in the first half of 2020, infecting millions of people globally, prompting major countries around the world to impose foot prohibitions and work stoppage orders. This report also examines the impact of the COVID-19 pandemic on the Infertility Treatment Devices and Equipment market, including supply chain analysis, impact assessments on the market size growth rate in various scenarios, and the measures that infertility treatment devices and equipment companies will take in response to the COVID-19 pandemic.

Global Infertility Treatment Devices and Equipment Market Scope

The infertility treatment devices and equipment market is segmented on the basis of type, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Ovum Aspiration Pumps
• Sperm Separation Devices
• Sperm Analyzer Systems
• Micromanipulator Systems
• Incubators
• Others

Procedure

• Assisted Reproductive Technology
• In Vitro Fertilization
• Intracytoplasmic Sperm Injection
• Others (GIFT, ZIFT, Surrogacy)
• Artificial Insemination
• Intrauterine Insemination
• Intratubal Insemination
• Intracervical Insemination
• Fertility Surgery
• Tubal Ligation Reversal
• Varicocelectomy
• Laparoscopy

Others (Laparotomy, Myomectomy, Microsurgical Reconstruction, Hysteroscopy)

End-User

• Fertility Clinics
• Hospitals and Other Healthcare Facilities
• Clinical Research Institutes

 Infertility Treatment Devices and Equipment Market Regional Analysis/Insights

The infertility treatment devices and equipment market is analysed and market size insights and trends are provided by country, type, procedure and end-user as referenced above.

The countries covered in the infertility treatment devices and equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America was the second-largest market in 2018 as the fertility rate in the U.S. was at a record low. There were only 62.5 births per 1,000 women, according to the National Center for Health Statistics.

Due to rise in the infertility rate in this region and increased awareness about available treatment choices, Asia Pacific is predicted to develop at the quickest rate in the next years. The availability of various reimbursement programmes in developed regions is expected to further promote regional expansion. For example, the Singapore government contributes about 75% of the cost of several ART operations.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure growth Installed base and New Technology Penetration

The infertility treatment devices and equipment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infertility treatment devices and equipment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infertility treatment devices and equipment market. The data is available for historic period 2010-2020.

Competitive Landscape and Infertility Treatment Devices and Equipment Market Share Analysis

Le paysage concurrentiel du marché des dispositifs et équipements de traitement de l'infertilité fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des dispositifs et équipements de traitement de l'infertilité.

Certains des principaux acteurs opérant sur le marché des dispositifs et équipements de traitement de l'infertilité sont :

• AB Scientific Ltd. (États-Unis)
• Art Biotech Pvt. Ltd. (Inde)
• Cuisinier (États-Unis)
• Dxnow, Inc. (États-Unis)
• Eppendorf SE (États-Unis)
• Esco Micro Pte. Ltd. (Singapour)
• Hamilton Thorne, Ltd. (États-Unis)
• LabIVF Asia Pte Ltd. (Singapour)
• Rocket Medical plc (Royaume-Uni)
• The Cooper Companies, Inc. (États-Unis)
• Vitrolife (Suède)
• Irvine Scientific (États-Unis)
• Microptique (États-Unis)
• The Cooper Companies Inc. (États-Unis)

SKU-68244